Men with nonseminomatous germ cell tumors (NSGCTs) who are at high risk of metastasis can benefit from retroperitoneal lymph node dissection (RPLND) as primary treatment, a recent study from Harvard ...
Please can you give a brief introduction to robotic RPLND and how this procedure has traditionally been performed? Robotic RPLND utilizes laparoscopy combined with robotic technology to perform ...
In patients with intermediate-risk or high-risk nonseminomatous testicular germ cell tumors (GCTs), adjunctive surgery is necessary. At some institutions, standard therapy includes four cycles of ...
Evaluation of the oncologic benefit of adjunctive surgery at time of postchemotherapy retroperitoneal lymph node dissection (PC-RPLND). This is an ASCO Meeting Abstract from the 2020 Genitourinary ...
Multifocal Ductal Carcinoma In Situ of the Breast: A Contraindication for Breast-Conserving Treatment? The prospect of primary chemotherapy to eradicate virtually all low- or limited volume ...
SAN FRANCISCO — Retroperitoneal lymph node dissection (RPLND) could potentially be a first-line option for men with stage II A/B testicular seminoma in order to reduce long-term toxicity and secondary ...
Surveillance plays a major role in the management of men with cancer clinically confined to the testis. Both the American Urological Association (AUA) and the European Association of Urology (EAU) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback